Study Comparing FOLFIRI with Cetuximab or Bevacizumab for First-Line Treatment in Patients with Metastatic Colorectal Cancer and Specific Genetic Profiles
- Substances:–
Italy- Participants:18–64 years · 65+ years
Rare diseases
Investigational molecules
Locations
ItalyStudy on the Effects of Ozanimod on Inflammation in Patients with Relapsing Multiple Sclerosis
ItalyStudy on the Effectiveness and Safety of IgM-Enriched Immunoglobulin Therapy for Patients with Septic Shock
ItalyStudy of KK8123 for Adults with X-linked Hypophosphatemia
FranceStudy on Doxapram for Treating Apnea in Preterm Newborns
BelgiumStudy on Metyrapone for Patients with Mild Autonomous Cortisol Secretion
NorwayStudy on the Safety of VO659 for Patients with Spinocerebellar Ataxia Types 1, 3, and Huntington's Disease
DenmarkEvaluating the effects of intravenous melatonin for preventing agitation and emergence delirium in children undergoing elective surgery
DenmarkStudy of BOLD-100 with FOLFOX chemotherapy (fluorouracil, folinic acid, and oxaliplatin) in patients with advanced gastrointestinal tumors, colorectal, gastric, or pancreatic cancer
GermanyStudy on the Effects of Sodium Lactate and Saline Solutions in Patients with Septic Shock
CzechiaA Study of FOLFIRINOX Drug Combination Before Surgery Compared to Immediate Surgery in Patients with Resectable Pancreatic Head Cancer
NorwayStudy on Psilocybin, Ketamine, and Midazolam for Treating Depression in Cancer Patients
CzechiaTell us about your condition – we search every trial in Europe and connect you with the right site.